New Horizon Europe Funding Boosts European Research in AI and Quantum Technologies

European CommissionThe European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in the realms of artificial intelligence (AI) and quantum technologies.

This includes substantial funding of €50 million fund to advance large AI models by integrating new data modalities and expanding their capabilities. This call targets the development of generative AI capable of processing and generating multimodal data, including but not limited to text, images, audio, video, and 3D representations, while adapting to a wide range of tasks and domains. With this funding, Europe aims to lead in creating AI systems that are not only powerful but also adhere to European values and ethical guidelines, particularly in view of the AI Act.

To address the need for transparency and robustness in AI €15 million will be invested in projects that will enhance the intelligibility and reliability of AI systems. The EU recognises the importance of AI systems that are not only intelligent but also understandable and safe for users, thus supporting the EU’s approach for human-centric AI.

€40 million will be invested to boost research into cutting-edge, world-leading quantum technologies. €25 million of this investment will be devoted to developing a network of quantum gravimeters throughout Europe. This will not only enhance precision in Earth observation and civil engineering. It will also show how quantum technologies can represent a significant improvement on current technological capabilities. The network will consist of at least eight gravimeters (gravity sensors), demonstrating how quantum gravimetry can offer much greater precision than its classical equivalent and serving as the basis for a future pan-European digital quantum sensing infrastructure.

In addition, there will be €15 million of investment focusing on stimulating transnational research and development in next-generation quantum technologies. These transnational research projects are expected to foster synergies among European stakeholders, ensuring that the EU remains at the forefront of the global quantum technology race, and cementing its position as a hub of innovation and technological self-reliance.

A further €6 million of investment aims to strengthen Europe's engagement in global ICT standardisation. By supporting the participation of European experts in international standard-setting bodies, the EU seeks to promote its interests and values in the development of global technical specifications and standards.

The remaining €1.5 million will see investment to explore Digital Humanism, a project that places people at the centre of the digital transformation. This approach emphasises the need for cross-disciplinary collaboration to ensure that the digital realm upholds European standards of law, social economy, and fundamental rights.

More information as regards the areas of activity for these calls (HORIZON-CL4-2024-DIGITAL-EMERGING-02, and HORIZON-CL4-2024-HUMAN-03) is available in the 2023-2025 Horizon Europe Digital, Industry, and Space work programme.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...